Immune Defense Protein Impact On Respiratory Immune Outcomes — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Immune Defense Protein Impact On Respiratory Immune Outcomes — Stella

Home/Upper Respiratory Disease/

View on ClinicalTrials.gov

Recruiting

Back to Upper Respiratory Disease trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

People Science, Inc., Los Angeles, California

Key details

Sponsor

Quantec Ltd

Collaborators

People Science, Inc.

Enrollment target

~300 participants

Started

December 2025

Primary completion

May 2026

Age range

60 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.